Primary Mediastinal Large B-Cell Lymphoma (PMLCL): The Need for Prospective Controlled Clinical Trials

References

• Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chean J. K. C., Cleary M. L., et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group Classification of the Non-Hodgkin's Lymphoma. Blood 1997; 89: 3909–3918
   PubMed Web of Science ®Google Scholar
• Anderson J. R., Armitage J. O., Weisemburger D. D. Epidemiology of the non-Hodgkin's lymphomas: Distribution of the major subtypes differ by geographic location. Ann Oncol 1998; 9: 717–720
   PubMed Web of Science ®Google Scholar
• Addis B. J., Isaacson P. G. Large cell lymphoma of the mediastinum: a B-cell tumor of probable thymic origin. Histopathology 1986; 10: 379–390
   PubMed Web of Science ®Google Scholar
• Menestrina F., Chilosi M., Bonetti F., et al. Medias-tinal large cell lymphoma of the B type, with sclerosis: histopathologic and immuno-histochemical study of eight cases. Histopathology 1986; 10: 589–600
   PubMed Web of Science ®Google Scholar
• Moller P., Lammler B., Eberlein-Gonska M., et al. Primary mediastinal clear cell lymphoma of B-cell type. Virchow Arch (Pathol Anal) 1986; 412: 79–92
   Web of Science ®Google Scholar
• Scarpa A., Bonetti E, Menestrina F., et al. Mediastinal large-cell lymphoma with sclerosis. Genotypic analysis established its B nature. virchows Arch; 1987; 412: 17–21
   Web of Science ®Google Scholar
• Lamarre L., Jacobson J. O., Aisenberg A. C., Hanis N. L. Primary large cell lymphoma of the mediastinum: A histologic and immunophenotypic study of 29 cases. Am J Surg Pathol 1989; 13: 730–739
   PubMed Web of Science ®Google Scholar
• Lazzarino M., Orlandi E., Paulli M., Boveri E., Morra A., Brusamolino E., Gianelli U., Gargantini L., et al. Primary mediastinal B-cell lymphoma with sclerosis: An aggressive tumor with distinct clinical and pathologic features. J Clin Oncol; 1993; 11: 2306–2316
   PubMed Web of Science ®Google Scholar
• Rohatiner A. Z. S., Whelan J. S., Ganjm R. K., Norton A. J., Wilson A., Lister T. A. Mediastinal large-cell lymphoma with sclerosis (MLCLS). Br J Cancer; 1994; 69: 601–604
   PubMed Web of Science ®Google Scholar
• Lazzarino M., Orlandi E., Paulli M., Striter J., Klersy C., Gianelli U., Gargantini L., et al. Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients. J Clin Oncol 1997; 15: 1646–1653
   PubMed Web of Science ®Google Scholar
• Aisenberg A. Primary large-cell lymphoma of the mediastinum. J Clin Oncol. 1993; 12: 2291–2294
   Google Scholar
• Miller J. B., Variakojis D., Bitran I. D., Sweet D., et al. Diffuse histiocytic lymphoma with sclerosis: a clini-copathologic entity frequently causing superior vena caval obstruction. Cancer 1981; 47: 748–756
   PubMed Web of Science ®Google Scholar
• Levitt L., Aisenberg A., Harris N., Linggood R., Poppema S. Primary non-Hodgkin's lymphoma of the mediastinurn. Cancer. 1982; 50: 2486–2492
   PubMed Web of Science ®Google Scholar
• Shaffer K., Smith D., Kim D., et al. Primary mediastinal large B-cell lymphoma: radiologic findings at presentation. Am J Roentgenol 1996; 167: 425–430
   PubMed Web of Science ®Google Scholar
• Trump D. L., Mann R. B. Diffuse large cell and undifferentiated lymphomas with prominent mediastinal involvement. A pr prognostis subset of patients with non-Hodgkin's lymphoma. Cancer 1982; 50: 277–282
   PubMed Web of Science ®Google Scholar
• Bertini M., Orsucci L., Vitolo U., Levis A., Tosdeschini G., Meneghini V., et al. Stage II large B-cell lymphoma with sclerosis treated with MACOP-B. Ann Oncol 1991; 2: 733–737
   PubMed Web of Science ®Google Scholar
• Jacobson J. O., Aisenberg A. C., Lamarre L., Willett C. G., Linggood R. M., Miketic L. M., Harris N. L. Mediastinal large cell lymphoma. An uncommon subset of adult lymphoma curable with combined modality. Cancer 1988; 62: 1893–1898
   PubMed Web of Science ®Google Scholar
• Kim D., Mauch P., Shaffer K., Pinkus G., Shipp M. A., Kaplan W. D., Tung N., Wheeler C., Beard C. J., Canellos G. P., Shulman L. N. Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients. J Clin Oncol 1993; 11: 1336–1343
   PubMed Web of Science ®Google Scholar
• Zinzani P. L., Bendandi M., Frezza G., et al. Rimary mediastinal B-cell lymphoma with sclerosis: clinical and therapeutic evaluation of 22 patients. Leuk Lymphoma 1996; 21: 311–316
   PubMed Web of Science ®Google Scholar
• Todeschini G., Ambrosetti A., Meneghini V. Mediastinal large B-cell lymphoma with sclerosis: a clinical study of 21 patients. J Clin Oncol 1990; 8: 804–808
   PubMed Web of Science ®Google Scholar
• MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis. Ann Oncol., M. P. Martelli, M. Martelli, E. Pescarmona, V. De Sanctis, V. Donato, E Palombi, E. Todisco, E. A. Rendha, E Man-Delli, 1998, in press).
   Google Scholar
• The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987–944
   PubMed Web of Science ®Google Scholar
• Zucca E., Martinelli G., Csontos S., Cavalli F. MACOP/CytaBEP a novel effective treatment for aggressive non Hodgkin's lymphomas. Proc Am Soc Clin Oncol (abstract) 1993; 12: 369
   Google Scholar
• Miller A. B. Recommendations for grading of acute and subacute toxicity (WHO criteria). Cancer. 1981; 47: 207
   PubMed Web of Science ®Google Scholar
• Cazals-Hatem D., Lepage E., Brice P., et al. Rimary mediastinal large B-cell lymphomas, a GELA (Groupe d'Etude des Lymphomes de l'Adulte) study. Am J Surg Pathol 1996; 20: 877–888
   PubMed Web of Science ®Google Scholar
• Fisher R. I., Gaynor E. R., Dahlberg S., et al. Comparison of standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993; 328: 1002–1006
   PubMed Web of Science ®Google Scholar
• Sehn L. H., Antin J. H., Shulman L. N., Mauch P., Elias A., Kadin M. E., Wheeler C. Primary diffuse large B-cell lymphoma of the mediastinum: outcome following highdose chemotherapy and autologous hematopietic cell transplantation. Blood 1998; 91: 717–723
   PubMed Web of Science ®Google Scholar
• Popat U., Przepiork D., Champlin R, Pugh W., Amin K., Mehra R., et al. High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome. J Clin Oncol 1998; 16: 63–69
   PubMed Web of Science ®Google Scholar